Cite

HARVARD Citation

    Doi, T. et al. (n.d.). First-in-man phase 1 study of TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. European journal of cancer. pp. S120-. [Online]. 
  
Back to record